Some pharmacokinetic observations of carbadox medication in pigs.
Concentrations of carbadox and a first metabolite, desoxycarbadox, were measured in contents of the porcine gastrointestinal tract after in-feed administration of carbadox in therapeutic dosages (100-150 ppm). The levels of carbadox in the relevant parts of the gastrointestinal tract were found to be lower than the MIC-values reported for enteropathogenic microorganisms at their sites of action. The presented observations do not provide a pharmacological rationale for the therapeutic use of carbadox in the treatment of dysentery and diarrhoea in swine. The carbadox levels encountered in the proximal part of the gut (stomach, duodenum) however, seem to indicate that in-feed administration of 50 ppm carbadox can provide an effective prophylaxis against Treponema hyodysenteriae, a causative agent in swine dysentery. The timecourse of the blood levels of carbadox and desoxycarbadox after in-feed administration of carbadox (50 ppm) and the concentration profiles in the gastrointestinal tract are discussed with regard to the disposition of this drug in pigs.
de Graaf
G J
GJ
Central Veterinary Institute, Lelystad, The Netherlands.
Jager
L P
LP
Baars
A J
AJ
Spierenburg
T J
TJ
D000821:Animal Feed; D000818:Animals; D002218:Carbadox / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000378:metabolism / Q000493:pharmacokinetics*; D004064:Digestive System / Q000378:metabolism*; D005503:Food Additives; D011810:Quinoxalines / Q000493:pharmacokinetics*; D013552:Swine / Q000378:metabolism*; D014018:Tissue Distribution
D005503:Food Additives; D011810:Quinoxalines; C043638:N,N'-desoxycarbadox; D002218:Carbadox